Jagged 1-Notch signaling determines β cell maturity and function
Jagged 1-Notch signaling determines β cell maturity and function
批准号:
10315442
负责人:
Nina Suda
金额:
$7.49万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-01 至 2023-08-31
关键词:
Beta CellBindingBlindnessCardiovascular systemCell physiologyCellsChronicClinicalDataDefectDevelopmentDiseaseDominant-Negative MutationEnd stage renal failureEndocrineEpidemicFailureFamilyFunctional disorderGeneticGlucoseGlucose IntoleranceGoalsHealth Care CostsHigh Fat DietHumanHyperglycemiaImmunofluorescence ImmunologicImpairmentIn VitroInsulinInsulin ResistanceKnockout MiceKnowledgeLigandsMammalsMeasuresMolecularMorbidity - disease rateMusNon-Insulin-Dependent Diabetes MellitusObese MiceObesityPancreasPathogenicityPathway interactionsPatientsPeripheralPharmacologyPhenotypePhysiologicalPrevalencePublishingReagentRecording of previous eventsResearch PersonnelRoleSignal TransductionSurfaceTestingTherapeuticTissuesToxic effectTrainingTranslatingVisualizationWorkadenoviral-mediatedblood glucose regulationdb/db mousediabetes pathogenesisfeedinggain of functionglucose tolerancein vivoinsulin secretionisletjagged1 proteinleptin receptorloss of functionmortalitymouse modelnotch proteinnovelnovel therapeutic interventionpreventreceptorresponseskillstranslational approach
中文摘要
摘要/文摘
英文摘要
Summary/Abstract
Obesity-induced Type 2 Diabetes (T2DM) continues to increase at an alarming rate resulting in a substantial
burden of long-term complications and healthcare costs. T2DM is now the leading cause of end-stage renal disease
and one of the leading causes of blindness worldwide, as well as a disproportionate contributor to cardiovascular
morbidity and mortality. As such, understanding mechanisms of T2DM pathogenesis is key in tackling the growing
prevalence in what some consider the largest epidemic in human history.
Although insulin resistance is the hallmark of Type 2 diabetes (T2DM), it manifests as hyperglycemia only in
the setting of β cell insufficiency. Pathophysiologic mechanisms underlying this failure requires further elucidation.
We have recently shown that Notch signaling is a novel regulator of β cell function, and glucose homeostasis. Notch
activity is regulated by ligand (Jagged 1/2, and Delta-like 1/3/4) availability. We find that islets isolated from HFD-fed
or leptin receptor-deficient db/db mice have increased Jagged1 expression as compared to chow or db/+ controls,
without change in other Notch ligands, in parallel to increased Notch activity. These data led us to hypothesize that
Jagged1 is both sufficient and necessary to transduce Notch signaling in β cells and is a potential regulator of β cell
function, maturity and glucose homeostasis (Aim 1 and Aim 2). To investigate this, we generated novel β cell specific
Jagged1 gain-of-function and knock-out mice. By identifying the ligand-receptor interaction, we postulate that we can
take advantage of this knowledge for therapeutic benefit. To this end, we have generated dominant negative mutants
of the Notch receptor lacking the intracellular Notch domain that specifically block either Jagged or Delta-like ligands.
As a translational approach, we will investigate if increased Jagged1 is also seen in islets from patients with and without
T2DM (Aim 3). The current data on Notch signaling in β cells shows promise for furthering the understanding of the
pathophysiology in T2DM. In studying this mechanism further, we hope to provide a novel therapeutic strategy in
preventing a disease that continues to be a growing concern worldwide.
This training plan will develop my skills in understanding determinants of β cell function and maturity in the
setting of hyperglycemia. The proposed study investigating Jagged 1-Notch signaling will be a stepping stone towards
my goal of becoming an independent researcher.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: